358 related articles for article (PubMed ID: 32002632)
21. Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure.
Lok DJ; Klip IT; Lok SI; Bruggink-André de la Porte PW; Badings E; van Wijngaarden J; Voors AA; de Boer RA; van Veldhuisen DJ; van der Meer P
Am J Cardiol; 2013 Sep; 112(6):831-7. PubMed ID: 23820571
[TBL] [Abstract][Full Text] [Related]
22. A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure.
Richter B; Koller L; Hohensinner PJ; Zorn G; Brekalo M; Berger R; Mörtl D; Maurer G; Pacher R; Huber K; Wojta J; Hülsmann M; Niessner A
Int J Cardiol; 2013 Sep; 168(2):1251-7. PubMed ID: 23218577
[TBL] [Abstract][Full Text] [Related]
23. [GDF-15 in plasma and circulating mononuclear cells and NT-proBNP for diagnosis of chronic heart failure and predicting cardiovascular disease events].
Xiangrui Q; Junhui L; Rui H; Xiaozhen Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1273-1279. PubMed ID: 31852642
[TBL] [Abstract][Full Text] [Related]
24. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
25. Variability of biomarkers in patients with chronic heart failure and healthy controls.
Meijers WC; van der Velde AR; Muller Kobold AC; Dijck-Brouwer J; Wu AH; Jaffe A; de Boer RA
Eur J Heart Fail; 2017 Mar; 19(3):357-365. PubMed ID: 27766733
[TBL] [Abstract][Full Text] [Related]
26. Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesity.
Baessler A; Strack C; Rousseva E; Wagner F; Bruxmeier J; Schmiedel M; Riegger G; Lahmann C; Loew T; Schmitz G; Fischer M
Eur J Heart Fail; 2012 Nov; 14(11):1240-8. PubMed ID: 22843563
[TBL] [Abstract][Full Text] [Related]
27. Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure.
Gürgöze MT; van Vark LC; Baart SJ; Kardys I; Akkerhuis KM; Manintveld OC; Postmus D; Hillege HL; Lesman-Leegte I; Asselbergs FW; Brunner-la-Rocca HP; van den Bos EJ; Orsel JG; de Ridder SPJ; Pinto YM; Boersma E
Circ Heart Fail; 2023 Jan; 16(1):e009526. PubMed ID: 36408685
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
Lowenthal A; Camacho BV; Lowenthal S; Natal-Hernandez L; Liszewski W; Hills NK; Fineman JR; Bernstein HS
Am J Cardiol; 2012 Mar; 109(6):866-72. PubMed ID: 22196786
[TBL] [Abstract][Full Text] [Related]
29. Growth differentiation factor 15 as mortality predictor in heart failure patients with non-reduced ejection fraction.
Mendez Fernandez AB; Ferrero-Gregori A; Garcia-Osuna A; Mirabet-Perez S; Pirla-Buxo MJ; Cinca-Cuscullola J; Ordonez-Llanos J; Roig Minguell E
ESC Heart Fail; 2020 Oct; 7(5):2223-2229. PubMed ID: 32589369
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of circulating microRNA-19b in heart failure.
Zhang L; Xu RL; Liu SX; Dong SH; Zhao XX; Zhang BL
Eur J Clin Invest; 2020 Nov; 50(11):e13308. PubMed ID: 32663314
[TBL] [Abstract][Full Text] [Related]
31. NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease.
Shimohata H; Usui J; Tawara-Iida T; Ebihara I; Ishizu T; Maeda Y; Kobayashi H; Numajiri D; Kaneshige A; Sega M; Yamashita M; Ohgi K; Maruyama H; Takayasu M; Hirayama K; Kobayashi M; Yamagata K;
Clin Exp Nephrol; 2024 May; 28(5):457-464. PubMed ID: 38238500
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
[TBL] [Abstract][Full Text] [Related]
33. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
[TBL] [Abstract][Full Text] [Related]
34. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F
Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324
[TBL] [Abstract][Full Text] [Related]
35. Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?
Fudim M; Kelly JP; Jones AD; AbouEzzeddine OF; Ambrosy AP; Greene SJ; Reddy YNV; Anstrom KJ; Alhanti B; Lewis GD; Hernandez AF; Felker GM
Am Heart J; 2020 Feb; 220():97-107. PubMed ID: 31805424
[TBL] [Abstract][Full Text] [Related]
36. The multi-biomarker approach for heart failure in patients with hypertension.
Bielecka-Dabrowa A; Gluba-Brzózka A; Michalska-Kasiczak M; Misztal M; Rysz J; Banach M
Int J Mol Sci; 2015 May; 16(5):10715-33. PubMed ID: 25984599
[TBL] [Abstract][Full Text] [Related]
37. The prognostic values of GDF-15 in comparison with NT-proBNP in patients with normotensive acute pulmonary embolism.
Duran L; Kayhan S; Guzel A; Ince M; Kati C; Akdemir HU; Yavuz Y; Zengin H; Okuyucu A; Murat N
Clin Lab; 2014; 60(8):1365-71. PubMed ID: 25185423
[TBL] [Abstract][Full Text] [Related]
38. Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial.
McKelvie RS; Komajda M; McMurray J; Zile M; Ptaszynska A; Donovan M; Carson P; Massie BM;
J Card Fail; 2010 Feb; 16(2):128-34. PubMed ID: 20142024
[TBL] [Abstract][Full Text] [Related]
39. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
[TBL] [Abstract][Full Text] [Related]
40. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.
Rhodes CJ; Wharton J; Howard LS; Gibbs JS; Wilkins MR
Heart; 2011 Jul; 97(13):1054-60. PubMed ID: 21558476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
